| 1 | 
                
                    LCK
                
             | 10件:  NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Yersinia infection, Human T-cell leukemia virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency | D03658 
                
                    D03658
                
             | 
                
                    Dasatinib
                
             | 2件:  51 51, 85 | 
| 2 | 
                
                    LCK
                
             | 10件:  NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Yersinia infection, Human T-cell leukemia virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency | D06414 
                
                    D06414
                
             | 
                
                    Dasatinib
                
             | 2件:  51 51, 85 | 
| 3 | 
                
                    LEPR
                
             | 6件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, AMPK signaling pathway, JAK-STAT signaling pathway, Adipocytokine signaling pathway, Non-alcoholic fatty liver disease | D05014 
                
                    D05014
                
             | 
                
                    Metreleptin
                
             | 1件:  265 265 | 
| 4 | 
                
                    LIPA
                
             | 3件:  Steroid biosynthesis Steroid biosynthesis, Lysosome, Cholesterol metabolism | D10377 
                
                    D10377
                
             | 
                
                    Sebelipase alfa
                
             | 1件:  19 19 | 
| 5 | 
                
                    LTA
                
             | 7件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection | D00742 
                
                    D00742
                
             | 
                
                    Etanercept
                
             | 17件:  15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285, 298 | 
| 6 | 
                
                    LTA
                
             | 7件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection | D10187 
                
                    D10187
                
             | 
                
                    Pateclizumab
                
             | 1件:  46 46 | 
| 7 | 
                
                    LTB
                
             | 3件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis | D08866 
                
                    D08866
                
             | 
                
                    Baminercept
                
             | 4件:  13 13, 46, 53, 97 | 
| 8 | 
                
                    LINGO1
                
             | - | D11767 
                
                    D11767
                
             | 
                
                    Opicinumab
                
             | 1件:  13 13 |